322
Table 7.1 (continued)
Polymer
Cyclodextrin
Pharmaceuticals
Technique
Outcomes offered by
cyclodextrin-based polymeric
nanoparticles
Reference
Poly (lactic acid and
glycolic acid)
Hydroxypropyl-βcyclodextrin
Formononetin
Neutralization agitation
method
Promising carrier for poor
lipophilic and poor
hydrophilic drugs
Guo et al.
(2017)
Poly (lactic acid and
glycolic acid)
β-Cyclodextrin
–
Emulsion evaporation process Enhanced internalization of
nanoparticles into the Caco-2
cells
GarcíaGonzález
et al. (2016)
Poly (ethylene
glycol)-poly
(ε-caprolactone)
Hydroxypropyl-βcyclodextrin
Zinc (II)
phthalocyanine as
drug carrier
Melting/sonication procedure Novel vehicle for the skin
delivery of highly lipophilic
compounds
Conte et al.
(2015)
A. Pandey
Table 7.1 (continued)
Polymer
Cyclodextrin
Pharmaceuticals
Technique
Outcomes offered by
cyclodextrin-based polymeric
nanoparticles
Reference
Poly (lactic acid and
glycolic acid)
Hydroxypropyl-βcyclodextrin
Formononetin
Neutralization agitation
method
Promising carrier for poor
lipophilic and poor
hydrophilic drugs
Guo et al.
(2017)
Poly (lactic acid and
glycolic acid)
β-Cyclodextrin
–
Emulsion evaporation process Enhanced internalization of
nanoparticles into the Caco-2
cells
GarcíaGonzález
et al. (2016)
Poly (ethylene
glycol)-poly
(ε-caprolactone)
Hydroxypropyl-βcyclodextrin
Zinc (II)
phthalocyanine as
drug carrier
Melting/sonication procedure Novel vehicle for the skin
delivery of highly lipophilic
compounds
Conte et al.
(2015)
A. Pandey
